Skip to content

MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE

COMPARISON OF MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE AND CONVENTIONAL OPHTHALMOLOGICAL CONSULTATION

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03437018
Acronym
TELERETINODIAB
Enrollment
97
Registered
2018-02-19
Start date
2019-10-10
Completion date
2022-06-16
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Keywords

moderate diabetic retinopathy, tele-expertise

Brief summary

The aim of this study is to evaluate the monitoring of moderate diabetic retinopathy by tele-expertise

Detailed description

This study compares 2 strategies of monitoring of moderate diabetic retinopathy (RD).After a consultation with an orthoptist for measurement of visual acuity, measurement of ocular tone by pulsed air tonometer, retinography pictures (9 photographs: one of the posterior pole and 8 of the retinal periphery) and Optical Coherence Tomography (OCT), results are evaluated on-site by an ophthalmologist and then sent through a secure medical online application to an ophthalmologist expert in RD for assessment. Each patient is his own control.

Interventions

OTHERmoderate diabetic retinopathy follow-up by tele-expertise

Consultation by an orthoptist to measure visual acuity, eye tone by pulsed air tonometer, and retinography images after pupillary dilatation (9 photographs: one of the posterior pole and 8 of the peripheral retina) and optical coherence tomography (OCT). The results are immediately evaluated on site by an ophthalmologist. The results are sent through a secure online medical application to a diabetic retinopathy specialist ophthalmologist for evaluation.

Sponsors

Centre Hospitalier Sud Francilien
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with complicated diabetes mellitus with moderate retinopathy

Exclusion criteria

* Patient deprived of liberty by judicial or administrative decision * Person subject to a legal protection measure * Patient already involved in another clinical trial protocol

Design outcomes

Primary

MeasureTime frameDescription
classification of diabetic retinopathy (DR)1 monthDR is classified in 3 stages : moderate non proliferative DR, severe non proliferative DR, and proliferative DR

Secondary

MeasureTime frameDescription
classification of macular edema1 monthmacular edema (ME) is classified in 4 stages : no ME , mild ME, moderate ME, severe ME
follow-up strategy1 monthfollow-up strategy can take to ways : no treatment required and continuation of the monitoring/ complementary exam or treatment required
medical time necessary for examination and analyse1 monthtime necessary for direct examination and analyse by ophthalmologist on-site and time necessary for remote analyse are measured

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAlfred Penfornis

Centre Hospitalier Sud Francilien

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026